SCHEMBL3927005

SCHEMBL3927005

CNC1(c2cccs2)CCC2(CC1)OCCO2

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.49
OPRL1 P41146 2/20 0.49
SLC6A4 P31645 1/20 0.40
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
LMNA P02545 3/20 0.36
ICMT O60725 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
TP53 P04637 2/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29101213 0.82 OPRM1 (0.49) OPRM1OPRL1SLC6A4LMNAKDM4E
SCHEMBL29101204 0.80 OPRM1 (0.53) OPRM1OPRL1SLC6A4HDAC3HDAC1
SCHEMBL24946122 0.78 SLC6A4 (0.57) OPRM1OPRL1SLC6A4HDAC3HDAC1
Hydrochloric Acid SCHEMBL6203736 0.77 SLC6A4 (0.55) OPRM1OPRL1SLC6A4HDAC3HDAC1
SCHEMBL3932959 0.76 OPRM1 (0.62) OPRM1OPRL1SLC6A3
SCHEMBL20887823 0.76 OPRM1 (0.47) OPRM1OPRL1LMNACYP2C9CYP2C19
Hydrochloric Acid SCHEMBL517163 0.75 OPRM1 (0.60) OPRM1OPRL1SLC6A3
SCHEMBL3924761 0.74 OPRM1 (0.48) OPRM1OPRL1SLC6A4HDAC3HDAC1
SCHEMBL734156 0.73 OPRM1 (0.57) OPRM1OPRL1SLC6A4SLC6A3ALDH1A1
SCHEMBL3934675 0.73 CYP2C9 (0.36) OPRM1OPRL1SLC6A4LMNAICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041142-B1 SPIROCYCLIC AZAINDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-10-09 EP disclosed
US-8399503-B2 Spirocyclic azaindole derivatives GRUENENTHAL GMBH (DE) 2013-03-19 US disclosed
US-20090156593-A1 Spirocyclic Azaindole Derivatives GRUNENTHAL GMBH (DE) 2009-06-18 US disclosed
EP-2041142-A1 SPIROCYCLIC AZAINDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-04-01 EP disclosed
WO-2008009416-A1 SPIROCYCLIC AZAINDOLE DERIVATIVES Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156593-A1 Spirocyclic Azaindole Derivatives AZI2, TPMT, AADAC OPRM1 1869/4885OPRL1 2512/4885SLC6A4 274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.